Core Points - Mingyang Technology (920663) closed at 21.71 yuan on October 15, 2025, marking a 5.9% increase from the previous trading day, with a total market capitalization of 2.899 billion yuan [1] - The company announced a cash dividend distribution plan for the first half of 2025, approved by the shareholders' meeting on August 27, 2025 [1] - The dividend distribution is based on a total share capital of 133,552,510 shares, with a payout of 2.246307 yuan per 10 shares, totaling approximately 30 million yuan [1] - The record date for the dividend is October 21, 2025, and the ex-dividend date is October 22, 2025 [1] - Cash dividends will be directly credited to shareholders' accounts by China Securities Depository and Clearing Corporation Limited, Beijing Branch [1] Financial Performance - The stock opened at 20.6 yuan, reached a high of 21.71 yuan, and a low of 20.51 yuan on the trading day [1] - The trading volume for the day was 47.7642 million yuan, with a turnover rate of 3.54% [1] Taxation Details - Individual shareholders and investment funds will be subject to differentiated individual income tax policies based on their holding periods [1] - Qualified foreign investors will have a withholding tax rate of 10%, resulting in an effective payout of 2.021676 yuan per 10 shares [1] - Other institutional investors and corporate shareholders are responsible for their own tax payments [1]

证券代码：837663 证券简称：明阳科技 公告编号：2025-119 明阳科技（苏州）股份有限公司 投资者关系活动记录表 □其他 二、 投资者关系活动情况 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 √特定对象调研 □业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 活动时间：2025 年 9 月 23 日 活动地点：公司会议室 参会单位及人员：东方财富证券 上市公司接待人员：董事、副总经理、董事会秘书沈旸，证券事务代表倪超 超 三、 投资者关系活动主要内容 本次投资者关系活动以线下会议方式展开，就投资者关心的问题进行了沟通 与交流。本次投资者关系活动的主要问题及公司对问题的回复情况如下： 问题 1：汽车电动化、智能化趋势对于公司产品市场规模的影响？ 回答：汽车电动化和智能化趋势下，用户对于汽车座椅的功能和舒适性提出 了更高的要求。因此，汽车座椅调节机构的数量增多，且电动调节逐渐代替手动 调节。公司重点开发并推广的调节机构总成件，适用于小桌板、扶 ...

Core Viewpoint - The article emphasizes the emergence of a new paradigm in China's economy, termed the "new new three samples," which includes robotics, artificial intelligence (AI), and innovative pharmaceuticals, as key drivers for high-quality economic development and a shift from traditional growth models to technology-led advancements [1][4][29]. Robotics Sector - The robotics sector has seen significant market capitalization growth, with companies like Huichuan Technology exceeding 200 billion yuan and several stocks doubling in price within the year [2][13]. - The market for industrial robots in China is projected to reach 302,000 units in 2024, maintaining its position as the largest industrial robot market globally [30]. - Key challenges include reliance on imported high-end servo motors and precision components, which need to be addressed to enhance domestic capabilities [33]. Artificial Intelligence Sector - The AI sector is characterized by a large number of high-value companies, with six firms exceeding a market cap of 100 billion yuan, including Cambricon and Hikvision [19]. - The demand for AI capabilities has surged, particularly in large model applications, leading to significant revenue growth for companies like Industrial Fulian and Cambricon, with year-on-year increases of 35.58% and 4347.82%, respectively [20]. - The sector is supported by national policies aimed at integrating AI into various industries, with a comprehensive action plan released to enhance AI's role in economic development [22]. Innovative Pharmaceuticals Sector - The innovative pharmaceuticals sector is represented by major players like Heng Rui Medicine, which is nearing a market cap of 500 billion yuan, and BeiGene, which recently achieved profitability [24][28]. - Recent policy measures have been introduced to support the development of innovative drugs, including streamlined approval processes and enhanced reimbursement mechanisms [27]. - The sector is witnessing a shift from loss-making to profitability, with companies like BeiGene demonstrating the commercial viability of innovative drug models [28]. Strategic Importance - The "new new three samples" signify a transition from scale-driven manufacturing to technology-driven innovation, crucial for enhancing China's global competitiveness and economic resilience [7][9][31]. - The collaboration among robotics, AI, and innovative pharmaceuticals creates a synergistic effect that strengthens overall productivity and fosters new business models [8][31]. - Addressing the "bottleneck" issues in these sectors is essential for sustaining growth and achieving leadership in global technology competition [32][33]. Policy Recommendations - To enhance competitiveness, policies should focus on data openness, regulatory reforms, and infrastructure development to support AI and innovative pharmaceuticals [35][38]. - Establishing a robust talent pipeline and fostering interdisciplinary education will be critical for sustaining innovation in these sectors [37][38]. - Encouraging public-private partnerships and international collaboration will further strengthen China's position in the global market [39].

证券代码：837663 证券简称：明阳科技 公告编号：2025-118 明阳科技（苏州）股份有限公司 回购股份注销完成暨股份变动公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、 定向回购股份注销情况 公司通过股份回购专用证券账户，共回购 303,680 股，占回购前公司总股本的比例 为 0.23%。公司已于 2025 年 9 月 10 日在中国证券登记结算有限责任公司北京分公司办 理完毕上述 303,680 股回购股份的注销手续。本次回购股份注销完成前，公司股份总额 为 133,856,190 股，本次回购股份注销完成后，公司股份总额为 133,552,510 股，公司剩 余库存股 0 股。 公司将按照规定办理工商变更登记手续,并申领新的营业执照。 四、 备查文件 | 类别 | 注销前 | | 注销后 | | | --- | --- | --- | --- | --- | | | 数量（股） | 比例（%） | 数量（股） | 比例（%） | | 1.有限售条件股份 | 70,593,353 | ...

东吴证券股份有限公司 关于明阳科技(苏州) 股份有限公司 | 事项 | 存在的问题 | 采取的措施 | | --- | --- | --- | | 1、信息披露 | | 不适用 | | 2、公司内部制度的建立和执行 | | 不适用 | | "三会"运作 | | 不适用 | l | 4、控股股东及实际控制人变动 | 元 | 不适用 | | --- | --- | --- | | 5、募集资金存放及使用 | 元 | 不适用 | | 6、关联交易 | 无 | 不适用 | | 7、对外担保 | 无 | 不适用 | | 8、收购、出售资产 | 无 | 不适用 | | 9、其他业务类别重要事项(包括对外投资、 | 元 | 不适用 | | 风险投资、委托理财、财务资助、套期保值等) | | | | 10、发行人或者聘请的中介机构配合保荐工作 | 元 | 不适用 | | 的情况 | | | 三、公司及股东承诺事项履行情况 2025 年半年度持续督导跟踪报告 根据《证券发行上市保荐业务管理办法》《北京证券交易所股票上市规则》 等有关法律法规、规范性文件等的规定,东吴证券股份有限公司(以下简称"东 吴证券"、"保荐机构"）作为明 ...

Group 1 - Huami New Materials surged over 13% [1] - Weike Technology increased by more than 10% [1] - Ningbo Huaxiang and Chaojie Co. both rose over 8% [1] - Shuangyi Technology, Mingyang Technology, and Yokogawa Precision also experienced gains [1]

Core Viewpoint - Mingyang Technology announced the election of Ms. Wang Meihua as the employee representative director during the first employee representative meeting scheduled for August 27, 2025 [2] Company Summary - The company will hold its first employee representative meeting on August 27, 2025 [2] - Ms. Wang Meihua has been elected as the employee representative director [2]

Core Viewpoint - Mingyang Technology announced the convening of its first employee representative meeting for 2025 on August 27, 2025, to vote on the proposal to elect Wang Meihua as the employee representative director of the company's fourth board of directors [2] Group 1 - The employee representative meeting is scheduled for August 27, 2025 [2] - The agenda includes the election of Wang Meihua as the employee representative director [2]

明阳科技（苏州）股份有限公司 董事变动公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、职工代表董事任命的基本情况 明阳科技（苏州）股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召开 2025 年第一次职工代表大会，审议并通过了《关于选举王美华为公司第四届董事会职工代表 董事的议案》。 选举王美华女士为公司职工代表董事，任职期限至第四届董事会届满之日止，自 2025 年 8 月 27 日起生效。该人员持有公司股份 0 股，占公司股本的 0.00%，不是失信 联合惩戒对象。 （上述人员简历详见附件） 二、董事离任的基本情况 证券代码：837663 证券简称：明阳科技 公告编号：2025-116 本公司沈如意先生，因个人原因辞任，自 2025 年 8 月 27 日起不再担任董事。该人 员持有公司股份 303,680 股，占公司股本的 0.23%，不是失信联合惩戒对象，离任后继 续担任副总经理职务，存在未履行完毕的公开承诺。 离任董事沈如意先生于公司向不特定合格投资者公开发行时作出的 ...

2025 年第一次职工代表大会决议公告 证券代码：837663 证券简称：明阳科技 公告编号：2025-115 明阳科技（苏州）股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间：2025 年 8 月 27 日 2、会议召开地点：公司会议室 3、会议召开方式：现场会议 1、议案内容： 根据《公司法》、《明阳科技（苏州）股份有限公司章程》、《北京证券交易 所股票上市规则》、《北京证券交易所上市公司持续监管办法（试行）》等的相关 4、发出职工代表大会会议通知的时间和方式：2025 年 8 月 17 日以书面通 知的方式发出 5、会议主持人：王美华女士 6、召开情况合法、合规、合章程性说明：本次会议的召开符合相关法律、 法规、规范性文件和公司章程的规定。 （二）会议出席情况 会议应出席职工代表 30 人，出席和授权出席职工代表 30 人 二、会议审议情况 （一） 审议通过《关于选举王美华为公司第四届董事会职工代表董事的议 案》 规定，职工 ...